207 related articles for article (PubMed ID: 22971104)
1. Flavonoids in the therapy and prophylaxis of flu: a patent review.
Costa SS; Couceiro JN; Silva IC; Malvar Ddo C; Coutinho MA; Camargo LM; Muzitano MF; Vanderlinde FA
Expert Opin Ther Pat; 2012 Oct; 22(10):1111-21. PubMed ID: 22971104
[TBL] [Abstract][Full Text] [Related]
2. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
Chamni S; De-Eknamkul W
Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
[TBL] [Abstract][Full Text] [Related]
3. Achieving clinical equality in an influenza pandemic: patent realities.
Kane EM
Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
[TBL] [Abstract][Full Text] [Related]
4. Non-hydrolyzed in digestive tract and blood natural L-carnosine peptide ("bioactivated Jewish penicillin") as a panacea of tomorrow for various flu ailments: signaling activity attenuating nitric oxide (NO) production, cytostasis, and NO-dependent inhibition of influenza virus replication in macrophages in the human body infected with the virulent swine influenza A (H1N1) virus.
Babizhayev MA; Deyev AI; Yegorov YE
J Basic Clin Physiol Pharmacol; 2013; 24(1):1-26. PubMed ID: 23425625
[TBL] [Abstract][Full Text] [Related]
5. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
Chawla R; Sharma RK; Bhardwaj JR
Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids from Matteuccia struthiopteris and Their Anti-influenza Virus (H1N1) Activity.
Li B; Ni Y; Zhu LJ; Wu FB; Yan F; Zhang X; Yao XS
J Nat Prod; 2015 May; 78(5):987-95. PubMed ID: 25927664
[TBL] [Abstract][Full Text] [Related]
7. Influenza drug resistance.
Pizzorno A; Abed Y; Boivin G
Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
[TBL] [Abstract][Full Text] [Related]
8. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
Ehrhardt C; Hrincius ER; Korte V; Mazur I; Droebner K; Poetter A; Dreschers S; Schmolke M; Planz O; Ludwig S
Antiviral Res; 2007 Oct; 76(1):38-47. PubMed ID: 17572513
[TBL] [Abstract][Full Text] [Related]
9. The potential for multidrug-resistant influenza.
van der Vries E; Schutten M; Boucher CA
Curr Opin Infect Dis; 2011 Dec; 24(6):599-604. PubMed ID: 22001947
[TBL] [Abstract][Full Text] [Related]
10. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
11. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
Liu AL; Wang HD; Lee SM; Wang YT; Du GH
Bioorg Med Chem; 2008 Aug; 16(15):7141-7. PubMed ID: 18640042
[TBL] [Abstract][Full Text] [Related]
13. Natural Product-Derived Phytochemicals for Influenza A Virus (H1N1) Prevention and Treatment.
Li R; Han Q; Li X; Liu X; Jiao W
Molecules; 2024 May; 29(10):. PubMed ID: 38792236
[TBL] [Abstract][Full Text] [Related]
14. Swine flu outbreak. What role for antiviral drugs?
Couzin-Frankel J
Science; 2009 May; 324(5928):705. PubMed ID: 19423784
[No Abstract] [Full Text] [Related]
15. Elderberry flavonoids bind to and prevent H1N1 infection in vitro.
Roschek B; Fink RC; McMichael MD; Li D; Alberte RS
Phytochemistry; 2009 Jul; 70(10):1255-61. PubMed ID: 19682714
[TBL] [Abstract][Full Text] [Related]
16. Antiviral drug treatment for emerging swine flu.
Wiwanitkit V
Clin Ter; 2009; 160(3):243-5. PubMed ID: 19756328
[TBL] [Abstract][Full Text] [Related]
17. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
[TBL] [Abstract][Full Text] [Related]
18. Bird flu, swine flu, and resistant influenza: the scary development of antiviral-resistant strains-part 2: novel A(H1N1): the flu we never expected.
O'Malley P
Clin Nurse Spec; 2009; 23(6):293-5. PubMed ID: 19858899
[No Abstract] [Full Text] [Related]
19. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
[TBL] [Abstract][Full Text] [Related]
20. Features of the new pandemic influenza A/H1N1/2009 virus: virology, epidemiology, clinical and public health aspects.
Tang JW; Shetty N; Lam TT
Curr Opin Pulm Med; 2010 May; 16(3):235-41. PubMed ID: 20375785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
